School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5707-10. doi: 10.1016/j.bmcl.2011.08.029. Epub 2011 Aug 12.
In our continued exploration of disubstituted piperazine derivatives as sigma (σ) receptor ligands with central nervous system (CNS) activity, a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazines (16-21 and 26-31) were synthesized, anticipating that these ligands would better suit the structural requirements of the current σ(1) pharmacophore. Affinities of these ligands for σ(1) and σ(2) receptors were investigated by means of radioligand binding assays, with the identification of N-(2-benzofuranylmethyl)-N'-[3-(4-methoxyphenyl)propyl]piperazine (29, K(i)=3.1 nM, σ(2)/σ(1)=45) as a selective σ(1) ligand. The σ(1) affinities and subtype selectivities of piperazines 16-21 and 26-31 were generally comparable to the corresponding benzylic analogs. Additionally, the affinities of 16-21 and 26-31 for the 5-HT(2B) receptor were much lower than the relatively nonselective methoxybenzylic analogs 2-4, indicating that elongation of the alkyl tether generally improved selectivity for σ(1) receptors.
在我们对具有中枢神经系统 (CNS) 活性的取代哌嗪衍生物作为 sigma (σ) 受体配体的持续探索中,合成了一系列 N-(2-苯并呋喃甲基)-N'-(甲氧基苯基烷基)哌嗪(16-21 和 26-31),预计这些配体将更好地符合当前 σ(1)药效团的结构要求。通过放射性配体结合测定法研究了这些配体对 σ(1)和 σ(2)受体的亲和力,确定了 N-(2-苯并呋喃甲基)-N'-[3-(4-甲氧基苯基)丙基]哌嗪(29,K(i)=3.1 nM,σ(2)/σ(1)=45)为选择性 σ(1)配体。哌嗪 16-21 和 26-31 的 σ(1)亲和力和亚型选择性通常与相应的苄基类似物相当。此外,16-21 和 26-31 对 5-HT(2B)受体的亲和力远低于相对非选择性的甲氧基苄基类似物 2-4,表明烷基连接体的延长通常提高了对 σ(1)受体的选择性。